Rennova Health Inc (NASDAQ:RNVA) has made public the price of underwritten public securities which the company says consist of Class A Units. The Class A Units were priced at $0.45 with each Class A Unit bearing a tag of one share of the Company’s common stock. Another would be earned after exercising a five-year warrant to procure one share of common stock. The offering is expected to bring in a total of $8,600,000 in gross proceeds before deducting any offering expenses or any underwriting discounts and commissions.
The company has granted a 45-day option to the underwriters to purchase with a tip of an additional 15% of the securities sold to cover over-allotments.
About the offer
The company’s warrants are approved for trading on the NASDAQ Capital Market. Its common stock also shows up on the NASDAQ Capital Market under the symbol “RNVA”. The securities registration has been filed with the Securities and Exchange Commission (the “SEC” having been declared effective as from July 13, 2016. However, the offering can only be made through a preliminary prospectus which must have had a previous filing with the SEC.
The sole book-running manager for the offering is Joseph Gunnar & Co., LLC though in an acting capacity.
More about Rennova Health
It is a well-known company across the United States given that it operates up to five free diagnostics laboratories that provide clinical testing services. It has a broad range of other services and software products the likes of a proprietary laboratory ordering and reporting application, an electronic health records platform as well as a superior laboratory information management system.
Apparently, despite stiff competition from other quarters, none of its competitors can match its level of software and the breadth of its services. The software enhances efficient and easy ordering and reporting which are very critical services of any process. After all, who does not want a superior way of ping things?
